Sialyl Lewis X Neoglycolipids
2454 2463
J(3,4) 3.3 Hz, 1H; 3e-H), 4.64 (d, J(1,2) 7.9 Hz, 1H; 1a-H), 4.77 (d,
J(1,2) 8.2 Hz, 1H; 1e-H), 4.80 (d, 2J 11.0 Hz, 1H; 6'c-H), 4.86 5.51 [m,
17H; HMQC: 4.88 (1c-H), 4.88 (4f-H), 4.89 (2e-H), 4.95 (2d-H), 4.95 (4e-
H), 4.97 (2b-H), 4.99 (5d-H), 5.12 (NfH), 5.15 (2a-H), 5.19 (3d-H), 5.31 (4d-
H), 5.32 (1d-H), 5.33 (4b-H), 5.35 (3a-H), 5.43 (7f-H), 5.47 (NcH), 5.50 (8f-
H)], 7.41 8.00 (m, 5H; C6H5); 13C NMR (151 MHz, CDCl3, excerpt): d
15.80 (6d-C), 37.61 (3f-C), 49.07 (5f-C), 53.15 (OCH3), 58.4 (2c-C), 60.92
(6c-C), 61.37 (6e-C), 61.52 (6b-C), 61.66 (9f-C), 62.17 (6a-C), 64.10 (5d-C),
66.58 (7f-C), 67.35 (4e-C), 67.57 (8f-C), 67.95 (3d-C), 68.80 (2d-C), 69.01
(4b-C, 1'-C), 69.41 (4f-C), 69.87 (2e-C), 70.04 (3'-C), 70.49 (OCH2), 70.93
(5e-C), 71.19 (5b-C), 71.23 (2b-C), 71.36 (3e-C), 71.51 (4d-C, OCH2), 71.86,
71.91 (2a-C, 6f-C), 72.29 (3a-C), 72.4 (3c-C), 72.87 (5a-C), 73.11 (5c-C),
74.23 (4c-C), 75.66 (4a-C), 75.96 (3b-C), 77.31 (2'-C), 95.26 (1d-C), 96.82
(2f-C), 99.39 (1c-C), 99.88 (1e-C), 100.69 (1b-C), 101.11 (1a-C), 165.11
H), 3.60 (5e-H), 3.63 (6k-H), 3.68 (3f-H), 3.69 (3d-H), 3.70 (4e-H), 3.71 (5f-
H), 3.73 (1'-H), 3.78 (4b-H), 3.83 (5i-H), 3.85 (4g-H), 3.85 (COOCH3), 3.92
(6'b-H), 3.92 (4c-H), 3.95 (4d-H), 3.96 (6f-H), 3.96 (6'f-H), 4.01 (6g-H), 4.03
(4a-H), 4.03 (5k-H), 4.05 (9k-H), 4.16 (6'd-H), 4.20 (3g-H), 4.23 (9k-H),
4.20 4.27 (6a-H, 6c-H, 6e-H, 6i-H), 4.31 (1f-H), 4.34 4.45 (6'a-H, 6'c-H,
6'e-H, 6'i-H), 4.41 (1b-H), 4.48 (1d-H), 4.51 (3i-H)], 4.61 (d, J(1,2) 7.7 Hz,
2H; 1a-H, 1c-H), 4.64 (d, J(1,2) 7.6 Hz, 1H; 1e-H), 4.68 5.51 [m, 24H;
HMQC: 4.76 (1i-H), 4.78 (6'g-H), 4.87 (2i-H), 4.88 (1g-H), 4.88 (4k-H), 4.92
(2f-H), 4.94 (2h-H), 4.95 (4i-H), 5.00 (5h-H), 5.04 (NkH), 5.07 (2e-H), 5.19
(3h-H), 5.20 (3e-H), 5.24 (2c-H), 5.30 (2b-H), 5.30 (2d-H), 5.30 (4f-H), 5.30
(4h-H), 5.31 (2a-H), 5.31 (1h-H), 5.37 (NgH), 5.43 (7k-H), 5.48 (3c-H), 5.50
(8k-H)], 5.59 (dd, J(2,3) J(3,4) 9.4 Hz, 1H; 3a-H), 7.02 8.08 (m, 55H;
11C6H5); 13C NMR (151 MHz, CDCl3, excerpt): d 15.8 (6h-C), 37.4 (3k-
C), 49.1 (5k-C), 53.1 (OCH3), 58.4 (2g-C), 60.8 (6g-C), 61.4 (6f-C), 61.6 (9k-
C), 62.7 (6b-C), 62.9 (6d-C), 64.1 (5h-C), 66.5 (7k-C), 67.3 (4i-C), 67.6 (8k-
C), 67.8 (4b-C), 67.9 (3h-C), 67.9 (4d-C), 68.8 (1'-C), 68.8 (2h-C), 68.9 (4f-C),
69.3 (2i-C), 69.8 (4k-C), 70.1 (3'-C), 70.3 (2b-C), 70.3 (2d-C), 70.4 (OCH2),
70.9 (5i-C), 71.1 (2f-C), 71.2 (5f-C), 71.3 (2e-C), 71.3 (3i-C), 71.4 (2c-C), 71.4
(OCH2), 71.5 (4h-C), 71.6 (2a-C), 71.9 (3e-C), 71.9 (6k-C), 72.1 (3c-C), 72.2
(5b-C), 72.3 (3g-H), 72.4 (5d-C), 72.5 (3a-C), 73.0 (5a-C), 73.0 (5c-C), 73.0
(5e-C), 73.1 (5g-C), 74.2 (4g-C), 75.2 (4c-C), 75.3 (4a-C), 75.9 (4e-C), 75.9
(3f-C), 77.2 (2'-C), 80.9 (3b-C), 80.9 (3d-C), 95.2 (1h-C), 99.3 (1g-C), 99.8
(1i-C), 100.4 (1b-C), 100.4 (1d-C), 100.7 (1f-C), 101.0 (1e-C), 101.1 (1a-C),
101.1 (1c-C); elemental analysis calcd (%) for C212H260N2O82 ¥ 3H2O
(4202.40): C 60.59, H 6.38, N 0.67; found: C 60.52 H 6.29, N 0.74.
(COPh), 167.84 (1f-C); elemental analysis calcd (%) for C118H180N2O52
¥
2H2O (2494.73): C 56.81, H 7.43, N 1.12; found: C 56.57 H 7.32, N 0.91.
Octasaccharide (19b): A solution of donor 16 (337 mg, 161 mmol) and lipid
17b[17] (445 mg, 321 mmol) in dry dichloromethane (5 mL) with molecular
sieves (AW-300) was treated at room temperature with trimethylsilyl
trifluoromethanesulfonate (12 mL, 64 mmol). After being stirred for 3 h, the
mixture was neutralized with triethylamine, filtrated and concentrated in
vacuo. The residue was purified by flash chromatography (toluene/acetone
8:5 to 1:1) to give 19b (254 mg, 47%) and unreacted 17b (301 mg) as
colourless foams. Rf 0.45 (toluene/acetone 1:1, HPTLC); [a]D 2.0
(c 1.0 in CHCl3); 1H NMR (600 MHz, CDCl3): d 0.88 (t, 6H; 2CH3),
1.16 (d, 3H; 6f-CH3), 1.25 1.30 (brs, 52H; 26CH2), 1.55 (q, 4H;
2OCH2CH2), 1.65 1.69 (m, 1H; 3h-Hax), 1.78 2.19 (m, 54H; 18COCH3),
2.58 (dd, 1H; 3h-Heq), 3.03 3.16 [m, 5H; HMQC: 3.05, 3.08 (OCH2CH2),
3.15 (5e-H)], 3.19 (dd, J(2',3') 5.4, 2J 10.3 Hz, 1H; 3'-H), 3.26 (dd,
J(2',3') 4.2, 2J 10.3 Hz, 1H; 3'-H), 3.31 3.50 [m, 6H; HMQC: 3.32
(OCH2), 3.39 (2'-H), 3.43 (5e-H), 3.47 (1'-H), 3.48 (5b-H)], 3.59 3.72 [m,
8H; HMQC: 3.59 (6b-H), 3.63 (5a-H), 3.62 (5c-H), 3.63 (6 h-H), 3.68 (3b-
H), 3.68 (3d-H), 3.70 (4c-H), 3.70 (5d-H)], 3.76 (dd, J(1',2') 4.8, 2J
10.5 Hz, 1H; 1'-H), 3.82 4.44 [m, 22H; HMQC: 3.83 (5g-H), 3.85 (4e-
H), 3.85 (COOCH3), 3.93 (4b-H), 3.93 (6d-H), 3.97 (6'd-H), 4.01 (6e-H),
4.02 (5h-H), 4.04 (6c-H), 4.06 (4a-H), 4.07 (9h-H), 4.19 (6'b-H), 4.21 (3e-H),
4.21 (6g-H), 4.23 (9h-H), 4.30 (6a-H), 4.32 (1d-H), 4.37 (6'g-H), 4.39 (6'a-
H), 4.42 (6'c-H)], 4.49 (d, J(1,2) 8.1 Hz, 1H; 1b-H), 4.51 (dd, J(2,3) 10.1,
J(3,4) 3.5 Hz, 1H; 3g-H), 4.64 (d, J(1,2) 8.0 Hz, 2H; 1a-H, 1c-H), 4.75
5.36 [m, 19H; HMQC: 4.75 (1g-H), 4.78 (6'e-H), 4.88 (1e-H), 4.88 (2g-H),
4.88 (4h-H), 4.92 (2d-H), 4.94 (2f-H), 4.95 (4g-H), 4.99 (5f-H), 5.05 (NhH),
5.07 (2c-H), 5.18 (3f-H), 5.19 (3c-H), 5.30 (4d-H), 5.30 (4f-H), 5.31 (1f-H),
5.33 (2b-H), 5.34 (2a-H), 5.35 (NeH)], 5.43 (dd, J(6,7) 2.9, J(7,8) 9.6 Hz,
1H; 7h-H), 5.50 (ddd, J(7,8) 9.5, J(8,9) J(8,9') ꢁ 3.3 Hz, 1H; 8f-H), 5.62
(dd, J(2,3) J(3,4) 9.5 Hz, 1H; 3a-H), 7.08 7.97 (m, 30H; 6C6H5);
13C NMR (151 MHz, CDCl3, excerpt): d 16.22 (6f-C), 37.75 (3h-C), 49.45
(5h-C), 53.61 (OCH3), 58.80 (2e-C), 61.25 (6e-C), 61.64 (6g-C), 61.79 (6d-
C), 62.09 (6c-C), 62.09 (9h-C), 62.87 (6a-C), 63.16 (6b-C), 64.49 (5f-C),
66.91 (7h-C), 67.68 (4g-C), 67.89 (8h-C), 68.31 (4b-C), 69.20 (1'-C), 69.22
(2f-C), 69.33 (4f-C), 69.80 (4h-C), 70.45 (3'-C), 70.12 (2g-C), 70.68 (2b-C),
71.30 (5g-C), 71.43 (2d-C), 71.59 (5d-C), 71.68 (2c-C), 71.70 (3g-C), 71.86
(4d-C), 72.18 (2a-C), 72.25 (6h-C), 72.39 (3c-C), 72.67 (3e-C), 72.74 (5b-C),
72.97 (3a-C), 73.29 (5a-C), 73.29 (5c-C), 73.48 (5e-C), 74.54 (4e-C), 75.89
(4c-C), 75.78 (4a-C), 76.27 (3d-C), 77.56 (2'-C), 81.31 (3b-C), 95.61 (1f-C),
99.76 (1e-C), 100.21 (1g-C), 100.94 (1b-C), 101.04 (1d-C), 101.44 (1a-C, 1c-
C); elemental analysis calcd (%) for C165H220N2O67 ¥ H2O (3321.55): C 59.67,
H 6.74, N 0.84; found: C 59.51 H 6.71, N 0.80.
Neoglycolipid 1a: Compound 19a (249 mg, 97.7 mmol) was dissolved in dry
methanol (50 mL), and sodium methoxide (126 mg, 3.3 mmol) was added.
After being stirred for 3 d at room temperature, the solution was
neutralized with Amberlite IR120 (H ), filtered and evaporated. The
residue was dissolved in dioxane/water (1:1, 30 mL), and an aqueous
solution of potassium hydroxide (0.2m, 1 mL) was added. After overnight
stirring, carbon dioxide was added, and the solution was evaporated in
vacuo. Flash chromatography (CHCl3/methanol/water/triethylamine
70:30:5:1) yielded 1a (153 mg, 83%) as
a colourless powder after
lyophilization from water. Rf 0.23 (CHCl3/methanol/0.2% aqueous CaCl2
1
65:35:8, HPTLC); H NMR (600 MHz, [D25]SDS/D2O): d 0.79 (m, 6H;
2CH3), 1.16 (d, J(5,6) 6.4 Hz, 3H; 6d-CH3), 1.21 1.31 (m, 61H; 26CH2,
N(CH2CH3)3), 1.57 (brs, 4H; 2OCH2CH2), 1.79 (t, 1H; 3f-Hax), 2.02, 2.03
(2s, 6H; 2COCH3), 2.75 (dd, 1H; 3f-Heq), 3.20 (q, 6H; N(CH2Me)3), 3.34
(dd, J(1,2) J(2,3) 8.4 Hz, 1H; 2a-H), 3.48 4.14 (m, 42H; 3a-H, 4a-H,
5a-H, 26a-H, 2b-H, 3b-H, 4b-H, 5b-H, 26b-H, 2c-H, 3c-H, 4c-H, 5c-H, 26c-
H, 2d-H, 3d-H, 4d-H, 2e-H, 3e-H, 4e-H, 5e-H, 26e-H, 4f-H, 5f-H, 6f-H, 7f-
H, 8f-H, 29f-H, 5H glycerol, 2O(CH2)(CH2)14), 4.43 (d, J(1,2) 7.8 Hz,
1H; 1a-H), 4.45 (d, J(1,2) 7.8 Hz, 1H; 1b-H), 4.51 (d, J(1,2) 7.8 Hz, 1H;
1e-H), 4.71 (1c-H (in HDO-signal)), 4.82 (q, J(5,6) 6.9 Hz, 1H; 5d-H),
5.12 (d, J(1,2) 3.9 Hz, 1H; 1d-H); FAB-MS (positive Mode, NBA/
glycerol/MeOH 1:1:1
HNEt32Na]; C84H157N3O35 (1769.16).8888
NaI): 1690 [M À NEt3Na], 1712 [M
À
Neoglycolipid 1b: Compound 19b (72 mg, 21.6 mmol) was treated as
described above to furnish 1b (39 mg, 86%) as a colourless powder after
flash chromatography (CHCl3/methanol/water/triethylamine 70:30:4:1 !
65:35:8:1). Rf 0.18 (CHCl3/methanol/0.2% aqueous CaCl2 65:35:8,
HPTLC); 1H NMR (600 MHz, [D25]SDS/D2O): d 0.82 (m, 6H; 2CH3),
1.17 (d, J(5,6) 6.4 Hz, 3H; 6d-CH3), 1.22 1.32 (m, 61H; 26CH2,
N(CH2CH3)3), 1.58 (brs, 4H; 2OCH2CH2), 1.80 (t, 1H; 3h-Ha), 2.03 (s,
6H; 2COCH3), 2.76 (d, 1H; 3h-He), 3.18 (q, 6H; N(CH2Me)3), 3.34 4.21
(m, 56H; 2a-H, 3a-H, 4a-H, 5a-H, 26a-H, 2b-H, 3b-H, 4b-H, 5b-H, 26b-H,
2c-H, 3c-H, 4c-H, 5c-H, 26c-H, 2d-H, 3d-H, 4d-H, 5d-H, 26d-H, 2e-H, 3e-
H, 4e-H, 5e-H, 26e-H, 2f-H, 3f-H, 4f-H, 2g-H, 3g-H, 4g-H, 5g-H, 26g-H,
3h-H, 4h-H, 5h-H, 6h-H, 7h-H, 8h-H, 29h-H, 5H glycerol,
2O(CH2)(CH2)14), 4.44 (d, 2H; 1a-H, 1d-H), 4.54 (m, 2H; 1b-H, 1f-H),
4.73 (brs, 2H; 1c-H, 1e-H (in HDO-signal)), 4.82 (q, 1H; 5f-H), 5.13 (brs,
1H; 1f-H); FAB-MS (positive mode, NBA/glycerol/MeOH 1:1:1 NaI):
Decasaccharide 19c: A solution of donor 16 (282 mg, 134 mmol) and lipid
17c[17] (609 mg, 271 mmol) in dry dichloromethane (6 mL) with molecular
sieves (AW-300) was treated at room temperature with trimethylsilyl
trifluoromethanesulfonate (10 mL, 54 mmol). After being stirred for 31³2 h,
the mixture was neutralized with triethylamine, filtrated and concentrated
in vacuo. The residue was purified by flash chromatography (toluene/
acetone 3:1 to 3:2) to give 19c (194 mg, 34%) and unreacted 17c (380 mg)
as colourless foams. Rf 0.46 (toluene/acetone 1:1, HPTLC); [a]D 14.2
(c 1.0 in CHCl3); 1H NMR (600 MHz, CDCl3): d 0.88 (t, 6H; 2CH3),
1.17 (d, 3H; 6h-CH3), 1.25 1.33 (m, 52H; 26CH2), 1.53 1.69 (m, 5H;
2OCH2CH2, 3k-Hax), 1.77 2.19 (m, 54H; 18COCH3), 2.58 (dd, 1H; 3k-
Heq), 3.02 4.52 [m, 54H; HMQC: 3.04, 3.08 (OCH2), 3.15 (2g-H), 3.17 (3'-
H), 3.25 (3'-H), 3.31 (OCH2), 3.32 (5b-H), 3.37 (2'-H), 3.43 (5g-H), 3.46 (1'-
H), 3.47 (6b-H), 3.52 (5d-H), 3.55 (3b-H), 3.58 (6d-H), 3.60 (5a-H), 3.60 (5c-
1993 [M À NEt3H], 2014 [M À NEt3Na]; C96H177N3O45 (2093.45).
Neoglycolipid 1c: Compound 19c (151 mg, 35.9 mmol) was treated as
described above to furnish 1c (80 mg, 92%) as a colourless powder after
flash chromatography (CHCl3/methanol/water/triethylamine 70:30:4:1 !
65:35:8:1). Rf 0.13 (CHCl3/methanol/0.2% aqueous CaCl2 65:35:8,
1
HPTLC); H NMR (600 MHz, [D25]SDS/D2O, excerpt): d 0.75 (m, 6H;
2CH3), 1.12 (d, J(5,6) 6.4 Hz, 3H; 6d-CH3), 1.17 1.27 (m, 61H; 26CH2,
N(CH2CH3)3), 1.53 (brs, 4H; 2OCH2CH2), 1.75 (t, 1H; 3j-Ha), 1.97, 1.98 (2
Chem. Eur. J. 2002, 8, No. 11
¹ WILEY-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002
0947-6539/02/0811-2461 $ 20.00+.50/0
2461